{"id":385760,"date":"2023-06-28T00:00:00","date_gmt":"2023-06-28T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47040448-medtech-breast-implants-and-reconstructive-devices-market-insights-us-2024\/"},"modified":"2026-03-31T10:12:18","modified_gmt":"2026-03-31T10:12:18","slug":"47040448-medtech-breast-implants-and-reconstructive-devices-market-insights-us-2024","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47040448-medtech-breast-implants-and-reconstructive-devices-market-insights-us-2024\/","title":{"rendered":"Breast Implants and Reconstructive Devices | Market Insights | US | 2024"},"content":{"rendered":"<p>The breast implant and reconstructive device market in the US is expected to experience\u00a0modest growth\u00a0over the forecast period, driven by factors such as a high aesthetic consciousness in the country, increasing awareness of the availability and benefits of breast reconstruction, and advancements in technologies. However, the market is also hindered by ongoing safety concerns related to breast implants and the potential for adverse events, such as capsular contracture and\u00a0BIA-ALCL. To mitigate these risks, manufacturers are investing in product development to improve implant safety and efficacy, as well as assessing both existing and emerging products in clinical studies;\u00a0the\u00a0FDA\u00a0is also increasing oversight of breast implants and reconstructive devices\u00a0to ensure patient safety.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for breast implants and reconstructive devices in the US from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-385760","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-breast-implants-and-reconstructive-devices","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385760\/revisions"}],"predecessor-version":[{"id":387272,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385760\/revisions\/387272"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}